The Effect of Hypertension Duration and the Age of Onset on CV Risk Factors Expression in Perimenopausal Women

Figures

• 

  Figure 1. Proportions of women with and without metabolic syndrome according to categories of hypertension duration (<5 years, N = 31; 5–10 years, N = 116; >10 years, N = 55). It indicates that the proportion of women with metabolic syndrome, compared to those without, increases in parallel with increased hypertension duration. The differences are statistically significant (p=0.025).

• 

  Figure 2. Categories of diabetes duration (<5, 5–10, >10 years) according to categories of hypertension duration (<5, 5–10, >10 years); patients diagnosed with diabetes mellitus type 2, N = 55. It indicates the relative frequencies (%) of categories of diabetes duration (<5, 5–10, >10 years) distributed across categories of hypertension duration (<5, 5–10, >10 years). The highest frequency (100%) was found for the category of diabetes duration of less than 5 years, indicating recent diabetes onset, in the category of hypertension duration of less than 5 years, compared to longer hypertension duration (Kruskal–Wallis ANOVA, p=0.003).

• 

  Figure 3. Linear correlation between BMI and total serum cholesterol in hypertensive menopausal women.

• 

  Figure 4. Linear correlation between waist circumference and total serum cholesterol in hypertensive menopausal women.

• 

  Figure 5. Relative frequencies of components of metabolic syndrome and other CV risk factors in hypertensive menopausal women according to categories of hypertension duration (<5, 5–10, >10 years). It shows the relative frequencies of particular components of MS and other CV risk factors among hypertensive menopausal women according to categories of hypertension duration (<5, 5–10, >10 years), presented graphically, as bar diagrams.